WALD – waldencast acquisition corp. - class a ordinary share (US:NASDAQ)
Stock Stats
News
Waldencast (NASDAQ:WALD) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler [Yahoo! Finance]
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
Waldencast (NASDAQ:WALD) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Waldencast (NASDAQ:WALD) was given a new $2.00 price target on by analysts at Jefferies Financial Group Inc..
Form 6-K Waldencast plc For: Jan 15
Form 6-K Waldencast plc For: Dec 19
Form EFFECT Waldencast plc
Form 424B3 Waldencast plc
Form F-3 Waldencast plc
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.